Medtronic Receives FDA Clearance for Pulse Oximetry System
The new technology is designed to improve oxygen saturation monitoring reliability across diverse skin tones and patient populations.
The new technology is designed to improve oxygen saturation monitoring reliability across diverse skin tones and patient populations.
Sedgwick’s latest report shows fewer medical device recall events in Q1 2026, while sterility-related recalls drove the majority of impacted units.
The agency recommendations emphasize using manufacturer-authorized accessories and avoiding overnight charging to reduce fire and injury risks.
The system uses artificial intelligence for image reconstruction to improve diagnostic precision and workflow efficiency in radiology, cardiology, and oncology.
The Food and Drug Administration identifies the software update and nebulizer restrictions as the most serious type of recall.
Admetsys announced that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
The U.S. FDA has proposed banning electrical stimulation devices for self-injurious or aggressive behavior due to significant risks, marking the second attempt at prohibition, with implications including potential treatment transitions for users and a thorough review of updated evidence and expert opinions.